A New Contender in AKI Prevention: LSALT Peptide E...
Category : Clinical Trial Update 24 March 2026Acute kidney injury (AKI) remains one of the most overlooked complications in modern medicine. Espec...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
ARIKAYCE Moves Earlier in Treatment: Phase 3b ENCO...
Category : Clinical Trial Update 24 March 2026For patients with MAC lung disease, treatment is long, complex, and often frustrating. Now, Insmed I...
A New Approach to Endometriosis: ENDO-205 Enters C...
Category : Clinical Trial Update 24 March 2026Endometriosis has long been treated as a symptom-management problem. Now, a new drug candidate is tr...
Biohaven Bets on “Better Weight Loss,” Not Just Mo...
Category : Clinical Trial Update 23 March 2026The obesity drug race is entering its next phase. Biohaven Ltd. has completed enrollment for a Phase...
GSK Scores a First: FDA Approves Lynavoy for Chron...
Category : Approval/Launch 23 March 2026Some conditions are overlooked—not because they’re rare, but because they’re misun...
Latest Newsletter Post
-
A New Approach to Endometriosis: EN..
24 March 2026
-
ARIKAYCE Moves Earlier in Treatment..
24 March 2026
-
A New Contender in AKI Prevention:..
24 March 2026
-
Alzheimer’s Drug LEQEMBI Shows Stro..
23 March 2026
-
Eris Lifesciences Disrupts the GLP-..
23 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com